News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SeraCare Life Sciences, Inc. (SRLS) to Report Fourth Quarter and Fiscal Year 2011 Results on November 17, 2011


11/14/2011 1:51:30 PM

MILFORD, Mass., Nov. 14, 2011 /PRNewswire/ -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS) will release its fourth quarter and fiscal year 2011 financial results before U.S. financial markets open on Thursday, November 17, 2011. SeraCare will host a conference call at 8:30 a.m. Eastern Time on the same day to review 2011 results.

(Logo: http://photos.prnewswire.com/prnh/20110324/NE70714LOGO )

The conference call will be webcast live over the Internet and can be accessed by logging on to the "Investor Center, Events" section of the SeraCare Life Sciences website at www.seracare.com. The call can also be accessed by dialing (800) 706-7741 (within the United States) or (617) 614-3471 (outside the United States). The passcode for participants is 15885680.

A replay of the call will be available approximately two hours after the live call concludes through November 24, 2011. To access the replay, dial (888) 286-8010 (within the United States) or 617-801-6888 (outside the United States). The passcode is 93812436. The webcast will also be archived on the Company's website.

About SeraCare Life Sciences, Inc.:

SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.

Contacts:
Gregory A. Gould
Interim President, Chief Executive Officer and Chief Financial Officer
SeraCare Life Sciences, Inc.
508-244-6400

Sarah Cavanaugh
MacDougall Biomedical Communications
781-235-3060

Tom Laughran
Fleishman-Hillard Inc.
312-729-3719

SOURCE SeraCare Life Sciences, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES